| Application no. and date | 19155538.2 (espacenet) (Federated) (European Patent Register), 20120420 | | Patent/reg. no. and date | DK/EP 3505528, 20201125 | | Publication date | 20190703 | | Priority no. and date | US 201161478040 P, 20110421, US 201161478038 P, 20110424, US 201261596692 P, 20120208, US 201261596690 P, 20120208 | | EP pub. no. and date |
EP 3505528 20190703 | | Effective date | | | Applicant/owner | GLAXO GROUP LIMITED, GSK Medicines Research Centre
Gunnels Wood Road
Stevenage, SG1 2NY, United Kingdom, GB | | Applicant ref. no. | 164417 | | Inventor | SWAYZE, Eric E., 2855 Gazelle Court
Carlsbad, CA 92010, US,
FREIER, Susan M., 2855 Gazelle Court
Carlsbad, CA 92010, US,
MCCALEB, Michael L., 2855 Gazelle Court
Carlsbad, CA 92010, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/7088 (2006.01) , C12N 15/113 (2010.01) , A61P 31/14 (2006.01) | | Title | MODULATION AF HEPATITIS-B-VIRUS (HBV)-EKSPRESSION | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
